Behind the Seizure™ program launch

December 14, 2016

Last week at the American Epilepsy Society meeting in Houston, we launched a very exciting new program with BioMarin Pharmaceutical Inc.

Behind the Seizure™ is a no charge epilepsy gene panel testing program for children age 3 years who experienced their first unprovoked seizures after the age of 2 years and meet certain clinical criteria.

In as little as 2 weeks, an epilepsy gene panel test can bring you and your patients closer to identifying the genetic cause and ensure they benefit from genetic insights early in their care including:

Tailoring care to a patient’s specific needs

Identifying potential clinical trials relevant to the diagnosis

Shortening the time to diagnosis

Identifying risk of disease for family members

Connecting families with patient advocacy organizations

To learn more about the program, eligibility, Invitae’s Epilepsy Panel, or to place an order, please click here.

“Genetic testing can play a transformative role in shortening the diagnostic odyssey for children with epilepsy. In addition, as our understanding of the genes associated with epilepsy rapidly expands, so does the potential for improving care. Helping children gain access to their genetic information early on can expand their options.”

—Dr. Raman Sankar, MD, PhD

If you have any questions or would like additional information, please do not hesitate to reach out to Client Services.